|
JPH0250488A
(ja)
*
|
1988-08-11 |
1990-02-20 |
Nec Corp |
超伝導配線
|
|
EP1294892B1
(en)
*
|
2000-06-23 |
2007-10-17 |
Wyeth Holdings Corporation |
Assembly of wild-type and chimeric influenza virus-like particles (vlps)
|
|
US9045727B2
(en)
|
2002-05-17 |
2015-06-02 |
Emory University |
Virus-like particles, methods of preparation, and immunogenic compositions
|
|
WO2004042001A2
(en)
*
|
2002-05-17 |
2004-05-21 |
Emory University |
Virus-like particles, methods of preparation, and immonogenic compositions
|
|
CA2490866A1
(en)
*
|
2002-06-26 |
2004-01-08 |
Advanced Bionutrition Corporation |
Viruses and virus-like particles for multiple antigen and target display
|
|
ES2217967B1
(es)
*
|
2003-03-31 |
2006-01-01 |
Consejo Sup. Investig. Cientificas |
Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv.
|
|
CA2526720C
(en)
|
2003-05-22 |
2013-10-22 |
Fraunhofer Usa, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
|
US8551756B2
(en)
*
|
2003-07-11 |
2013-10-08 |
Novavax, Inc. |
Avian influenza chimeric VLPS
|
|
AU2011218606B2
(en)
*
|
2003-07-11 |
2012-01-12 |
Novavax, Inc |
Functional influenza virus-like particles (VLPS)
|
|
US8592197B2
(en)
*
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
US8080255B2
(en)
|
2003-07-11 |
2011-12-20 |
Novavax Inc. |
Functional influenza virus like particles (VLPs)
|
|
US8992939B2
(en)
|
2003-07-11 |
2015-03-31 |
Novavax, Inc. |
Highly efficient influenza matrix (M1) proteins
|
|
US8506967B2
(en)
|
2003-07-11 |
2013-08-13 |
Novavax, Inc. |
Functional influenza virus like particles (VLPs)
|
|
ES2307346B1
(es)
*
|
2004-01-21 |
2009-11-13 |
Consejo Sup. Investig. Cientificas |
Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
|
|
ES2307345B1
(es)
*
|
2004-01-21 |
2009-11-13 |
Consejo Sup. Investig. Cientificas |
Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
|
|
EP2848692B1
(en)
*
|
2004-05-21 |
2017-08-16 |
Novartis Vaccines and Diagnostics, Inc. |
Alphavirus vectors for influenza virus vaccines
|
|
EP1858332A4
(en)
*
|
2005-02-16 |
2011-06-22 |
Lentigen Corp |
LENTIVIRUS VECTORS AND ITS USE
|
|
ES2310062B1
(es)
|
2005-07-15 |
2009-11-13 |
Bionostra, S.L. |
Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
|
|
CA2616859C
(en)
|
2005-08-03 |
2015-04-14 |
Fraunhofer Usa, Inc. |
Compositions and methods for production of immunoglobulins
|
|
BRPI0617486A2
(pt)
*
|
2005-10-18 |
2011-07-26 |
Novavax Inc |
vacina que compreende partÍculas similares a vÍrus da gripe funcionais (vlp) e uso de uma vlp de gripe
|
|
PT2529747T
(pt)
|
2005-12-02 |
2018-05-09 |
Icahn School Med Mount Sinai |
Vírus da doença de newcastle quiméricos que apresentam proteínas de superfície não nativas e suas utilizações
|
|
WO2007066334A1
(en)
*
|
2005-12-06 |
2007-06-14 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Improved influenza vaccine
|
|
MX2008009929A
(es)
*
|
2006-02-02 |
2008-10-01 |
Globeimmune Inc |
Vacuna a base de levadura para inducir una respuesta inmune.
|
|
AU2007215080A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Influenza antigens, vaccine compositions, and related methods
|
|
WO2008048344A2
(en)
*
|
2006-02-13 |
2008-04-24 |
Fraunhofer Usa, Inc. |
Bacillus anthracis antigens, vaccine compositions, and related methods
|
|
BRPI0707779B8
(pt)
*
|
2006-02-13 |
2021-05-25 |
Fraunhofer Usa Inc |
antígeno isolado, composição de vacina e método para produção de uma proteína antígeno
|
|
EP2476432B1
(en)
|
2006-03-07 |
2015-08-19 |
Vaxinnate Corporation |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
WO2007126788A2
(en)
*
|
2006-03-27 |
2007-11-08 |
Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for the treatment and prevention of viral infection
|
|
US7682619B2
(en)
|
2006-04-06 |
2010-03-23 |
Cornell Research Foundation, Inc. |
Canine influenza virus
|
|
WO2007130327A2
(en)
*
|
2006-05-01 |
2007-11-15 |
Technovax, Inc. |
Influenza virus-like particle (vlp) compositions
|
|
WO2007130330A2
(en)
*
|
2006-05-01 |
2007-11-15 |
Technovax, Inc. |
Polyvalent influenza virus-like particle (vlp) compositions
|
|
KR100702034B1
(ko)
*
|
2006-05-12 |
2007-03-30 |
삼성전자주식회사 |
반도체 장치, 이 장치의 전원 노이즈 감소 방법 및 인쇄회로 기판
|
|
US8153115B2
(en)
|
2006-06-15 |
2012-04-10 |
Ben-Gurion University Of The Negev Research And Development Authority |
Virus-like particles for treatment of viral infections
|
|
US20100184832A1
(en)
|
2006-07-14 |
2010-07-22 |
Sanofi Pasteur Biologics Co. |
Construction of Recombinant Virus Vaccines by Direct Transposon-Mediated Insertion of Foreign Immunologic Determinants into Vector Virus Proteins
|
|
WO2008094200A2
(en)
*
|
2006-07-27 |
2008-08-07 |
Ligocyte Pharmaceuticals, Inc |
Chimeric virus-like particles
|
|
WO2008094197A2
(en)
|
2006-07-27 |
2008-08-07 |
Ligocyte Pharmaceuticals, Inc. |
Chimeric influenza virus-like particles
|
|
WO2008100290A2
(en)
|
2006-09-29 |
2008-08-21 |
Sanofi Pasteur Biologics Co |
Recombinant rhinovirus vectors
|
|
WO2008058396A1
(en)
*
|
2006-11-15 |
2008-05-22 |
Folia Biotech Inc. |
Papaya mosaic virus-based vaccines for influenza
|
|
PL2121011T3
(pl)
*
|
2006-12-06 |
2014-10-31 |
Novartis Ag |
Szczepionki zawierające antygeny czterech szczepów wirusa grypy
|
|
US7998487B2
(en)
*
|
2007-02-16 |
2011-08-16 |
The Salk Institute For Biological Studies |
Antitoxin and vaccine platform based on nodavirus VLPs
|
|
BRPI0810865A2
(pt)
*
|
2007-04-28 |
2017-05-09 |
Fraunhofer Usa Inc |
antígenos de tripanossoma, composições vacinais, e métodos relacionados
|
|
WO2008148104A1
(en)
|
2007-05-25 |
2008-12-04 |
Novavax, Inc. |
Novel vlps derived from cells that do not express a viral matrix or core protein
|
|
US8404252B2
(en)
*
|
2007-07-11 |
2013-03-26 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
|
ES2539818T3
(es)
|
2007-08-02 |
2015-07-06 |
Biondvax Pharmaceuticals Ltd. |
Vacunas contra la gripe multiepitópicas multiméricas
|
|
CA2696764A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Fraunhofer Usa, Inc. |
Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
|
|
KR101956910B1
(ko)
*
|
2008-01-21 |
2019-03-12 |
메디카고 인코포레이티드 |
헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(ＶＬＰｓ)
|
|
SG190562A1
(en)
|
2008-04-18 |
2013-06-28 |
Vaxinnate Corp |
Deletion mutants of flagellin and methods of use
|
|
US20110206727A1
(en)
*
|
2008-07-30 |
2011-08-25 |
Denis Leclerc |
Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof
|
|
WO2010037046A1
(en)
|
2008-09-28 |
2010-04-01 |
Fraunhofer Usa, Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
|
EP3173097A3
(en)
|
2009-02-10 |
2017-07-12 |
Seqirus UK Limited |
Influenza vaccines with reduced amounts of squalene
|
|
AU2010243489A1
(en)
*
|
2009-05-01 |
2011-12-22 |
Redbiotec Ag |
Recombinant virus-like particles encoded by multi-gene vector
|
|
US20120058145A1
(en)
*
|
2009-05-08 |
2012-03-08 |
Bruno Rene Andre |
Method for producing virus from cell culture involving homogenization
|
|
PL222497B1
(pl)
*
|
2009-06-26 |
2016-08-31 |
Inst Biochemii I Biofizyki Pan |
Wektorowa cząsteczka wirusopodobna, sposób jej wytwarzania, kompozycja farmaceutyczna oraz zastosowanie wektorowej cząsteczki wirusopodobnej
|
|
CA2766899C
(en)
|
2009-07-02 |
2021-05-04 |
Massachusetts Institute Of Technology |
Compositions and methods for diagnosing and/or treating influenza infection
|
|
US8784819B2
(en)
|
2009-09-29 |
2014-07-22 |
Ibio Inc. |
Influenza hemagglutinin antibodies, compositions and related methods
|
|
US20110097358A1
(en)
*
|
2009-10-12 |
2011-04-28 |
Techno Vax, Inc. |
RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)
|
|
WO2011056899A2
(en)
|
2009-11-03 |
2011-05-12 |
Ligocyte Pharmaceuticals, Inc. |
Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps
|
|
CN107746869A
(zh)
*
|
2009-12-28 |
2018-03-02 |
赛诺菲疫苗技术公司 |
微藻中异源多肽的生产，微藻胞外体、组合物及其制备方法和用途
|
|
US20130028933A1
(en)
*
|
2009-12-28 |
2013-01-31 |
Ligocyte Pharmaceuticals, Inc. |
Methods for stabilizing influenza antigen enveloped virus-based virus-like particle solutions
|
|
US9352031B2
(en)
|
2010-02-18 |
2016-05-31 |
Technovax, Inc. |
Universal virus-like particle (VLP) influenza vaccines
|
|
CN102370976B
(zh)
*
|
2010-08-09 |
2014-06-11 |
中山大学 |
猪流感病毒和猪口蹄疫病毒的混合病毒样颗粒、制备方法和应用
|
|
CN102373182A
(zh)
*
|
2010-08-09 |
2012-03-14 |
中山大学 |
禽流感和传染性囊病混合病毒样颗粒、制备方法和应用
|
|
CN102373181B
(zh)
*
|
2010-08-09 |
2014-06-11 |
中山大学 |
猪流感病毒和猪蓝耳病病毒混合病毒样颗粒、制备方法和应用
|
|
CN102373183A
(zh)
*
|
2010-08-09 |
2012-03-14 |
中山大学 |
禽流感和新城疫混合病毒样颗粒、制备方法和应用
|
|
CN102373184A
(zh)
*
|
2010-08-09 |
2012-03-14 |
中山大学 |
禽流感和传染性支气管炎混合病毒样颗粒、制备方法和应用
|
|
JP2013541528A
(ja)
|
2010-09-21 |
2013-11-14 |
マサチューセッツ インスティテュート オブ テクノロジー |
ヒト適応ｈａポリペプチド、ワクチン、およびインフルエンザの処置
|
|
AU2011312178B2
(en)
|
2010-10-04 |
2016-05-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
|
US9821051B1
(en)
|
2010-10-28 |
2017-11-21 |
Seqirus UK Limited |
Reducing hospitalization in elderly influenza vaccine recipients
|
|
WO2012114323A1
(en)
|
2011-02-22 |
2012-08-30 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
JP6113155B2
(ja)
*
|
2011-06-20 |
2017-04-12 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
計算で最適化した広い反応性を示すｈ１ｎ１インフルエンザの抗原
|
|
EP2739307B1
(en)
*
|
2011-08-01 |
2017-09-06 |
Emory University |
Vlps containing ligands and methods related thereto
|
|
IN2014CN02114A
(enExample)
*
|
2011-09-20 |
2015-05-29 |
Sinai School Medicine |
|
|
IN2014DN07152A
(enExample)
|
2012-03-22 |
2015-04-24 |
Fraunhofer Usa Inc |
|
|
CA2868330A1
(en)
|
2012-03-30 |
2013-10-03 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for h5n1 and h1n1 influenza viruses
|
|
TWI434933B
(zh)
*
|
2012-04-17 |
2014-04-21 |
Nat Univ Tsing Hua |
抗多型禽流感病毒之ｄｎａ疫苗及其組合物
|
|
US8932598B2
(en)
|
2012-08-28 |
2015-01-13 |
Vaxinnate Corporation |
Fusion proteins and methods of use
|
|
SG11201503989PA
(en)
*
|
2012-11-27 |
2015-06-29 |
Univ Pittsburgh |
Computationally optimized broadly reactive antigens for h1n1 influenza
|
|
EP4154907A1
(en)
|
2012-12-18 |
2023-03-29 |
Icahn School of Medicine at Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
US10080792B2
(en)
|
2013-09-23 |
2018-09-25 |
Engen Bio, Inc. |
Influenza vaccine and therapy
|
|
CN104436157A
(zh)
|
2013-09-23 |
2015-03-25 |
恩金生物有限公司 |
流感疫苗和治疗
|
|
JP2018504412A
(ja)
|
2015-01-23 |
2018-02-15 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルスワクチン接種レジメン
|
|
KR101729387B1
(ko)
|
2015-04-17 |
2017-04-21 |
경희대학교 산학협력단 |
곤충세포 발현시스템을 이용한 인플루엔자 백신 소재 ｍ1-ｍ2-ｎａ-ｈａ 바이러스 유사 입자의 제조방법
|
|
US10426829B2
(en)
|
2015-09-03 |
2019-10-01 |
Novavax, Inc. |
Vaccine compositions having improved stability and immunogenicity
|
|
WO2017044890A1
(en)
*
|
2015-09-10 |
2017-03-16 |
Academia Sinica |
Bird flu vaccine combination comprising virus-like particles and novel adjuvants
|
|
WO2017218624A1
(en)
|
2016-06-15 |
2017-12-21 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus hemagglutinin proteins and uses thereof
|
|
WO2018080889A1
(en)
*
|
2016-10-31 |
2018-05-03 |
Georgia State University Research Foundation, Inc. |
A virus like particle of hepatitis b virus pre-s protein
|
|
EP3592381A1
(en)
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Cancer vaccine
|
|
US11254733B2
(en)
|
2017-04-07 |
2022-02-22 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza B virus neuraminidase antibodies and uses thereof
|
|
CN111801345A
(zh)
|
2017-07-28 |
2020-10-20 |
哈佛大学的校长及成员们 |
使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
|
|
EP3810634A4
(en)
|
2018-06-21 |
2022-07-27 |
Icahn School of Medicine at Mount Sinai |
Mosaic influenza virus hemagglutinin polypeptides and uses thereof
|
|
CN111315407B
(zh)
|
2018-09-11 |
2023-05-02 |
上海市公共卫生临床中心 |
一种广谱抗流感疫苗免疫原及其应用
|
|
MX2023012554A
(es)
|
2018-12-12 |
2023-11-08 |
Cambridge Tech Llc |
Vacuna universal contra la gripe.
|
|
US12351837B2
(en)
|
2019-01-23 |
2025-07-08 |
The Broad Institute, Inc. |
Supernegatively charged proteins and uses thereof
|
|
US12473543B2
(en)
|
2019-04-17 |
2025-11-18 |
The Broad Institute, Inc. |
Adenine base editors with reduced off-target effects
|
|
CN114258398A
(zh)
|
2019-06-13 |
2022-03-29 |
总医院公司 |
工程化的人内源性病毒样颗粒及使用其递送至细胞的方法
|
|
BR112023001272A2
(pt)
|
2020-07-24 |
2023-04-04 |
Massachusetts Gen Hospital |
Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
|
|
CN116063409A
(zh)
*
|
2022-09-09 |
2023-05-05 |
中山大学·深圳 |
一种乙型流感Mosaic重组蛋白、重组质粒及其构建方法和应用
|